Not every patient who develops gastroparesis or vision loss while taking a GLP-1 drug is informed by their physician of the potential link at the time of diagnosis
Some note that patients on niacinamide formulations report slightly better energy levels compared to those on plain semaglutide
Retatrutide and Blood Sugar Control Evidence indicates that retatrutide can improve glucose handling by encouraging insulin secretion while reducing glucagon release after meals [3]
And, of course, with an experienced GMS clinician guiding you every step of the way
While, previously, patients with severe OSA would likely require CPAP therapy for the remainder of their lives, especially as OSA tends to worsen with age and weight increase, these obesity-targeting medications offer the potential for some patients to become less dependent on CPAP or be managed using lower, more tolerable pressures. Indeed, patients on tirzepatide had about a 50% reduction in the apnea-hypopnea index and significant improvements in hypoxemia